Gastro-Hep News

European Commission Approves Fifth Adalimumab Biosimilar On September 20, 2018, the European Commission (EC) granted marketing authorization for the adalimumab (Humira, AbbVie) biosimilar Hulio (Mylan and […]

Introduction to Biosimilar Use in Patients With Inflammatory Bowel Disease

G&H What is a biosimilar? GL According to the US Food and Drug Administration (FDA), a biosimilar is a product that is highly similar to […]